Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report

被引：0
|
作者：
T. Anders Olsen
Dylan J. Martini
Sean T. Evans
Jamie M. Goldman
Mehmet Asim Bilen
机构：
[1] Emory University School of Medicine,Department of Hematology and Medical Oncology
[2] Winship Cancer Institute of Emory University,undefined
来源：
Journal of Medical Case Reports | / 15卷
关键词：
Case report; Methemoglobinemia; Immunotherapy; Adverse events and renal cell carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report
    Olsen, T. Anders
    Martini, Dylan J.
    Evans, Sean T.
    Goldman, Jamie M.
    Bilen, Mehmet Asim
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [2] Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report
    Katsumata, Yuki
    Kawasaki, Yoshihide
    Tanaka, Kayu
    Nakayama, Daisuke
    Katayama, Hiromichi
    Shimada, Shuichi
    Satake, Yohei
    Sato, Takuma
    Kawamorita, Naoki
    Yamashita, Shinichi
    Sato, Testuya
    Shoji, Kosuke
    Mitsuzuka, Koji
    Ito, Akihiro
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1522 - 1529
  • [3] Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy
    Yoshimura, Akihiro
    Yamamoto, Yoshiyuki
    Nishikawa, Tatsuya
    Fujita, Masashi
    Inoue, Takako
    Kondo, Fuki
    Hayashi, Takuji
    Kawamura, Norihiko
    Nagahara, Akira
    Nakai, Yasutomo
    Nakayama, Masashi
    Nishimura, Kazuo
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (01): : 26 - 32
  • [4] Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy
    Akihiro Yoshimura
    Yoshiyuki Yamamoto
    Tatsuya Nishikawa
    Masashi Fujita
    Takako Inoue
    Fuki Kondo
    Takuji Hayashi
    Norihiko Kawamura
    Akira Nagahara
    Yasutomo Nakai
    Masashi Nakayama
    Kazuo Nishimura
    International Cancer Conference Journal, 2024, 13 (1) : 26 - 32
  • [5] Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib
    Airo, Giulia
    Maffezzoli, Michele
    Lazzarin, Alessandro
    Bianconcini, Michele
    Greco, Alessandro
    Buti, Sebastiano
    Leonetti, Alessandro
    IMMUNOTHERAPY, 2022, 14 (16) : 1297 - 1305
  • [6] Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature
    Beirat, Amir F.
    Menakuru, Sasmith R.
    Khan, Ibrahim
    Siddiqui, Salahuddin
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 30 - 35
  • [7] Efficacy of combination therapy with pembrolizumab and axitinib for metastatic renal collecting duct cell carcinoma: A report on two cases
    Tamada, Shinji
    Ikarashi, Daiki
    Tsuyukubo, Takashi
    Iwasaki, Kazuhiro
    Isurugi, Kazumasa
    Ono, Sadahide
    Takata, Ryo
    Fujisawa, Hiromitsu
    Obara, Wataru
    IJU CASE REPORTS, 2022, 5 (06) : 438 - 441
  • [8] Multiorgan failure caused by pembrolizumab and axitinib in a woman affected by metastatic clear cell renal cell carcinoma: A case report and literature review
    Di Marco, Andrea
    Artioli, Grazia
    Favaretto, Adolfo
    Cavasin, Nicolo
    Basso, Umberto
    MEDICINE, 2024, 103 (13) : E37606
  • [9] Combination of pembrolizumab and axitinib: a new gold standard in the first-line therapy for metastatic clear-cell renal-cell carcinoma?
    Gafanov, R. A.
    Dzidzaria, A. G.
    Kravtsov, I. B.
    Fastovets, S., V
    ONKOUROLOGIYA, 2020, 16 (03): : 29 - 37
  • [10] Hypopituitarism induced by pembrolizumab plus axitinib in the treatment of metastatic renal cell carcinoma: A case report
    Hanawa, Kazushi
    Sawada, Norifumi
    Aikawa, Junki
    Otake, Yuko
    Kasai, Yoshifumi
    Mochizuki, Keito
    Shimura, Hiroshi
    Mochizuki, Takanori
    Kira, Satoru
    Mitsui, Takahiko
    ONCOLOGY LETTERS, 2024, 27 (02)
12345